SCHEMBL344147

SCHEMBL344147

COC1(C)C=CC(C(=O)c2ccccc2)=C(O)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPK1 P28482 3/20 0.36
HSD17B10 Q99714 3/20 0.36
ALOX15 P16050 2/20 0.36
ALDH1A1 P00352 7/20 0.36
LMNA P02545 6/20 0.35
HPGD P15428 4/20 0.35
HTT P42858 3/20 0.35
CYP3A4 P08684 2/20 0.35
CYP1A2 P05177 1/20 0.35
PGR P06401 1/20 0.35
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
PDE4A P27815 1/20 0.35
CYP2C19 P33261 1/20 0.35
HRH1 P35367 1/20 0.35
SLC6A3 Q01959 1/20 0.35
PDE4D Q08499 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29047177 0.85 ALDH1A1 (0.35) MAPTKDM4EMAPK1HSD17B10ALDH1A1
SCHEMBL3120605 0.84 ALDH1A1 (0.37) MAPTKDM4EMAPK1HSD17B10ALOX15
Salicylic Acid SCHEMBL5942970 0.82 KDM4E (0.35) MAPTKDM4EMAPK1HSD17B10ALDH1A1
SCHEMBL180233 0.82 MAPT (0.35) MAPTKDM4EMAPK1HSD17B10ALOX15
SCHEMBL29047178 0.82 MAPT (0.35) MAPTKDM4EMAPK1HSD17B10ALOX15
SCHEMBL9732809 0.82 MAPT (0.35) MAPTKDM4EMAPK1HSD17B10ALOX15
SCHEMBL29429342 0.81 L3MBTL1 (0.40) MAPTKDM4EMAPK1ALDH1A1LMNA
SCHEMBL29119739 0.81 KMT2A (0.36) MAPTKDM4EMAPK1HSD17B10ALOX15
SCHEMBL29119762 0.80 ELANE (0.35) MAPTKDM4EMAPK1HSD17B10ALOX15
SCHEMBL8166860 0.79 MAPT (0.39) MAPTKDM4EMAPK1HSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 578 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117597403-A Composition and method for protecting a coating from harmful effects of exposure to UV-C light 塞特工业公司 2024-02-23 CN claimed
CN-116783246-A Compositions and methods for protecting organic polymeric materials from discoloration due to exposure to UV-C light 塞特工业公司 2023-09-19 CN claimed
CN-116745353-A Compositions and methods for protecting organic polymeric materials from the deleterious effects of UV-C light exposure 塞特工业公司 2023-09-12 CN claimed
WO-2009080427-A1 METHOD FOR PRODUCING UV-ABSORBING HYBRID MATERIALS BASF SE (DE) 2009-07-02 WO claimed
EP-4289275-B1 INSECT REPELLENT COMPOSITION UNIV WIEN BODENKULTUR (AT) 2026-05-27 EP disclosed
US-20250359546-A1 NOVEL INSECT REPELLENT COMPOSITION UNIVERSITÄT FÜR BODENKULTUR WIEN (AT) 2025-11-27 US disclosed
EP-2384193-B1 VITAMIN D PROMOTING SUNSCREEN ARMSTRONG ERNEST T (US) 2025-08-06 EP disclosed
EP-3663366-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2025-01-08 EP disclosed
CN-118338957-A Oil-in-water type composition 株式会社资生堂 2024-07-12 CN disclosed
CN-113164433-B Oily moisturizer and external composition for skin containing same 日清奥利友集团株式会社 2024-07-09 CN disclosed
CN-118255914-A Copolymer having carbosiloxane dendrimer structure, and composition, cosmetic raw material, film-forming agent and cosmetic containing the copolymer 陶氏东丽株式会社 2024-06-28 CN disclosed
US-20240207153-A1 DESFERRIOXAMINES AND COMPOSITION CONTAINING UV LIGHT PROTECTION FILTERS EVONIK DR. STRAETMANS GMBH (DE) 2024-06-27 US disclosed
WO-1994021241-A1 NEW USE OF ANTI-ACNE AGENTS BEIERSDORF AG (DE) 1994-09-29 WO disclosed
WO-1994017780-A1 WATERPROOF COSMETIC OR DERMATOLOGICAL PHOTOPROTECTIVE PREPARATIONS BEIERSDORF AG (DE) 1994-08-18 WO disclosed
WO-1994014412-A1 SYNERGISTIC COMBINATIONS OF ACTIVE SUBSTANCE FOR THE COSMETIC OR DERMATOLOGICAL CARE OF THE SKIN, HAIR AND NAILS BEIERSDORF AG (DE) 1994-07-07 WO disclosed
EP-0431755-B1 Cosmetic composition UNILEVER PLC (GB) 1994-01-26 EP disclosed
US-5152983-A Mixture of 1,3-propanedione, 1-(4-methoxy-5-benzofurnyl)-3-phenyl and a carrier for topical application to human skin or hair CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) 1992-10-06 US disclosed
EP-0431755-A1 Cosmetic composition UNILEVER PLC (GB) 1991-06-12 EP disclosed
EP-0190326-A1 WEATHERABLE ABRASION RESISTANT ETHERIFIED AMINOPLAST DERIVED COATING FOR PLASTIC SUBSTRATES GENERAL ELECTRIC COMPANY (US) 1986-08-13 EP disclosed
WO-1986001217-A1 WEATHERABLE ABRASION RESISTANT ETHERIFIED AMINOPLAST DERIVED COATING FOR PLASTIC SUBSTRATES GENERAL ELECTRIC COMPANY (US) 1986-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359546-A1 NOVEL INSECT REPELLENT COMPOSITION EXOSC10, EPCAM, ICAM1 MAPT 1204/4885KDM4E 2960/4885MAPK1 3131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.